|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
SCIDIR_on1032680326 |
| 003 |
OCoLC |
| 005 |
20231120010220.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
171004t20182018enka ob 001 0 eng d |
| 040 |
|
|
|a IDEBK
|b eng
|e rda
|e pn
|c IDEBK
|d OCLCO
|d OCLCQ
|d IDEBK
|d OCLCO
|d YDX
|d N$T
|d OPELS
|d EBLCP
|d MERER
|d OCLCF
|d UPM
|d D6H
|d GZM
|d CHVBK
|d OCLCO
|d AU@
|d OCLCO
|d ESU
|d WYU
|d U3W
|d OCLCO
|d OCLCA
|d OCLCQ
|d S2H
|d OCLCO
|d VT2
|d OCLCQ
|d OCLCO
|d K6U
|d OCL
|d OCLCQ
|d CASUM
|
| 019 |
|
|
|a 1004563488
|a 1004724446
|a 1004826433
|a 1066453473
|a 1162215632
|a 1235844547
|a 1259587548
|
| 020 |
|
|
|a 0128104929
|q (ebk)
|
| 020 |
|
|
|a 9780128104927
|
| 020 |
|
|
|z 0128104910
|
| 020 |
|
|
|z 9780128104910
|
| 035 |
|
|
|a (OCoLC)1032680326
|z (OCoLC)1004563488
|z (OCoLC)1004724446
|z (OCoLC)1004826433
|z (OCoLC)1066453473
|z (OCoLC)1162215632
|z (OCoLC)1235844547
|z (OCoLC)1259587548
|
| 050 |
|
4 |
|a RD598.35.A77
|b M42 2018eb
|
| 072 |
|
7 |
|a MED
|x 085000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 617.4/1
|2 23
|
| 245 |
0 |
0 |
|a Mechanical circulatory and respiratory support /
|c editors, Shaun D. Gregory, Michael C. Stevens, John F. Fraser.
|
| 264 |
|
1 |
|a London :
|b Academic Press,
|c [2018]
|
| 264 |
|
4 |
|c �2018
|
| 300 |
|
|
|a 1 online resource (xxxiii, 818 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Front Cover; Mechanical Circulatory and Respiratory Support; Copyright; Contents; Contributors; Preface; Acknowledgments; Part 1: Heart failure and nondevice treatment; Chapter 1: Descent into heart and lung failure; Introduction; Cardiac Anatomy and Physiology; Heart Chambers; Heart Valves and Coronary Arteries; Left Ventricular Mechanics; LV performance-Pressure vs. volume curves; Myocardial oxygen consumption; Cardiogenic Shock; Chronic Heart Failure; Cardiac remodeling; Pathophysiology of chronic heart failure; Etiology; Heart failure: A progressive and multisystem disorder.
|
| 505 |
8 |
|
|a Cardio-renal syndromePulmonary hypertension secondary to left heart disease; Right heart failure; Grading heart failure; Defining and recognizing stage D; Heart failure with preserved ejection fraction (HFpEF); Treatment of HR with reduced ejection fraction; Respiratory Anatomy and Physiology; Structure and Function; Lung volumes; Gas exchange; The alveolar capillary membrane; Ventilation perfusion ratios in health and disease; Control of breathing: Chemical and neural mechanisms; The oxygen cascade; Respiratory Pathophysiology; Causes of respiratory failure; Asthma.
|
| 505 |
8 |
|
|a Acute respiratory distress syndromeTreatment options; Conclusion; References; Further Reading; Chapter 2: Heart and lung transplantation; Introduction; History of Thoracic Transplantation; Decision-Making in Thoracic Transplantation; Recipient Evaluation, Indications, Contraindications for Heart and Lung Transplantation; Indications for Heart, Lung, and Heart-Lung Transplantation; Listing for Heart Transplantation; Listing for Lung Transplantation; Listing for Heart-Lung Transplantation; Contraindications to Heart and Lung Transplantation; Specific Contraindications To Heart Transplantation.
|
| 505 |
8 |
|
|a Specific Contraindications to Lung TransplantationSpecific Listing Indications in Heart and Lung Transplantation; Multiorgan Transplantation; The Heart and Lung Donor; The Effects of Brain Death on Donor Heart and Lung Function; Heart and Lung Donor Selection; Selection of Donor Hearts; Selection of Donor Lungs; Donor-Recipient Matching in Heart and Lung Transplantation; Donor-Recipient Size Matching; Immunological Matching; Surgical Techniques; Donor Heart and Lung Procurement; Donor Procurement Operation; Technique of orthotopic cardiac transplantation; Technique of lung transplantation.
|
| 505 |
8 |
|
|a ImmunosuppressionImmunosuppression Agents; T-Cell Directed Therapy; Agents targeting signal 1; Agents targeting signal 2; B-Cell Directed Therapy [45]; B-cell targeting; Plasma cell targeting; Complement inhibition; Other targets; Agents Targeting Cytokines; Nonspecific cytokine inhibition; Specific cytokine inhibition; IL-2 receptor antagonist; Pooled Polyclonal Antibodies as Immunosuppressive Agents; Immune globulins; Polyclonal antithymocyte globulins; Immunosuppressive Agents With Multiple Cellular Targets; Antiproliferative agents: mTOR inhibitors; Antimetabolites.
|
| 650 |
|
0 |
|a Blood
|x Circulation, Artificial.
|
| 650 |
|
0 |
|a Artificial respiration.
|
| 650 |
|
0 |
|a Heart, Artificial.
|
| 650 |
1 |
2 |
|a Assisted Circulation
|0 (DNLM)D001243
|
| 650 |
1 |
2 |
|a Heart-Assist Devices
|0 (DNLM)D006353
|
| 650 |
2 |
2 |
|a Heart, Artificial
|0 (DNLM)D006354
|
| 650 |
|
2 |
|a Respiration, Artificial
|0 (DNLM)D012121
|
| 650 |
|
6 |
|a Circulation extracorporelle.
|0 (CaQQLa)201-0064847
|
| 650 |
|
6 |
|a Respiration artificielle.
|0 (CaQQLa)201-0048449
|
| 650 |
|
6 |
|a C�ur artificiel.
|0 (CaQQLa)201-0051640
|
| 650 |
|
7 |
|a MEDICAL
|x Surgery
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a Heart, Artificial.
|2 fast
|0 (OCoLC)fst00953756
|
| 650 |
|
7 |
|a Artificial respiration.
|2 fast
|0 (OCoLC)fst00817338
|
| 650 |
|
7 |
|a Blood
|x Circulation, Artificial.
|2 fast
|0 (OCoLC)fst00834566
|
| 655 |
|
4 |
|a Internet Resources.
|
| 655 |
|
4 |
|a Charts.
|
| 700 |
1 |
|
|a Fraser, John F.,
|e editor.
|
| 700 |
1 |
|
|a Gregory, Shaun D.,
|e editor.
|
| 700 |
1 |
|
|a Stevens, Michael C.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|z 9780128104927
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128104910
|z Texto completo
|
